Cancer Patients May Not Have Higher Covid-19 Risk
Brian Blum via Israel21c – Throughout the Covid-19 pandemic, it has been assumed that cancer patients were in the highest at-risk group. An early study from China seemed to confirm this. In…
COVID Report Raises Questions About Fatality Rate, and Studies Show Sugar Puts You at Risk
News Staff via CBN News – New numbers from the CDC reveal 94 percent of Americans who have died from COVID-19 already had underlying health problems. This reinforces what doctors have been…
As Number of COVID-19 Infections Drop, the President Announces FDA-Authorized Plasma Treatment
News Staff via CBN News – There’s some good news in the fight against the Coronavirus. The number of new infections has dropped to the lowest level in two months. The news comes…
Blood Pressure Medication Improves COVID-19 Survival Rates
University of East Anglia via EurekAlert – Medication for high blood pressure could improve Covid-19 survival rates and reduce the severity of infection – according to new research from the University…
Absolute Antibody Offers SARS-CoV-2 Neutralizing Antibodies Derived from COVID-19 Patients
News Staff via News-Medical Net – Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with…
Israel Starts Clinical Trial of Plasma-Derived Covid Drug
Abigail Klein Leichman via Israel21c – 12 patients are receiving Kamada’s immunoglobulin for coronavirus disease; so far, three patients were well enough to go home from the hospital. Physicians at Hadassah University…
Study of 300 COVID-19 Patients Shows Efficacy of Convalescent Plasma Therapy
Elsevier via News-Medical Net – A preliminary analysis of an ongoing study of more than 300 COVID-19 patients treated with convalescent plasma therapy at Houston Methodist suggests the treatment is safe…
Malaria Discovery Could Expedite Antiviral Treatment for COVID-19
Royal Melbourne Institute of Technology (RMIT) University via Newswise – New research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself, could offer effective treatment for…
People May Have a Pre-Existing Immune Response to COVID-19 Thanks to Common Colds
Angela Betsaida B. Laguipo, BSN via News-Medical Net – A new study shows that some people have immune responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes…
COVID Treatment Offers Instant Immunity, and It’s Already Available
Staff at CBN News – Nationwide, new cases of COVID-19 are declining, dropping 14 percent in the last two weeks. But on the local level, cases are still rising in at least…
School Children Unlikely to Play a Significant Role in COVID-19 Spread
Sally Robertson, B.Sc. via News-Medical Net – A study conducted by researchers in Finland suggests that children who are exposed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools are unlikely…
Coronavirus Makes Changes That Cause Cells Not to Recognize It
North Carolina State University via EurekAlert – With an alarm code, we can enter a building without bells going off. It turns out that the SARS coronavirus 2 (SARS-CoV-2) has the…
Genetic Mutations Predispose Individuals to Severe COVID-19
Rabound University Medical Center via EurekAlert – Current observations suggest that the coronavirus SARS-CoV-2 causes severe symptoms mainly in elderly patients with chronic disease. However when two pairs of previously healthy…
Why Is Obesity So Common in COVID-19 Patients?
Pennington Biomedical Research Center via Newswise – A hormone that connects the body’s metabolism and immune response system may explain why COVID-19 is so dangerous for people with obesity. “The problem…
Nitric Oxide Treatment Can Be Pivotal in the Fight Against COVID-19
George Washington University via News-Medical Net – Nitric oxide treatment can be pivotal in the world’s fight against SARS-CoV-2, the coronavirus that causes COVID-19, according to a review from the George…
